Semaglutide Cost Dallas-Fort Worth TX: 2026 Pricing, Insurance & Savings Guide

DFW Semaglutide Pricing Overview

Semaglutide costs $99 to $400 per month across the Dallas-Fort Worth metroplex as of March 2026, based on cash-pay pricing published by 40 clinics we verified through direct outreach, website review, and public pricing pages [1]. The DFW average is $311 per month, which is 4% below the national average of $325 for compounded semaglutide reported by Hims & Hers Health in their Q4 2025 earnings call [2].

These prices reflect compounded semaglutide, not branded Wegovy or Ozempic. Branded semaglutide lists at $1,349 per month for Wegovy (the FDA-approved weight-loss formulation) and $935 per month for Ozempic (the type 2 diabetes formulation), before any insurance or manufacturer discount [3]. The vast majority of DFW weight-loss clinics prescribe compounded semaglutide, which is legally produced by 503B compounding pharmacies while the FDA shortage designation remains in effect [4].

Three primary factors drive the price variance across DFW clinics. First, medication source: clinics sourcing from higher-volume compounding pharmacies like Empower Pharmacy (Houston) or Hallandale Compounding Pharmacy tend to price 10-15% lower than clinics using smaller local compounders [5]. Second, monitoring intensity: the three clinics offering weekly check-ins (Vital Wellness, The Aesthetics Society, Q Day Walk-In) charge $299-350/month, while monthly-monitoring clinics range more broadly from $99 to $400 [1]. Third, practice type matters — med spas and aesthetics clinics average $322/month, while internal medicine and direct primary care practices average $303/month across our dataset.

We surveyed clinics across Dallas, Fort Worth, Plano, Frisco, Southlake, and Farmers Branch. Eight DFW cities (Arlington, Irving, McKinney, Coppell, Flower Mound, Highland Park, University Park, Allen, and Prosper) had no dedicated semaglutide clinics in our dataset, though residents in those cities are typically within 15-25 minutes of multiple providers in neighboring cities. Our methodology is documented in our verification methodology page.

Clinic-by-Clinic Semaglutide Pricing

The following table lists every DFW clinic in our verified dataset, sorted by cash price from lowest to highest. All prices are monthly and reflect the standard maintenance dose. Promotional first-month pricing is noted separately. None of these clinics pay SemaVerified for placement [1].

Prices verified March 21, 2026 via clinic websites, direct calls, and published pricing pages. *Promotional first-month price; ongoing monthly cost not publicly disclosed. SemaVerified receives no compensation from any listed clinic. See our editorial policy for details.

Cash Pay vs Insurance: What You Will Actually Pay

Cash-pay patients in DFW spend $249 to $400 per month on semaglutide at standard maintenance doses, with the median falling at $325/month across our 40-clinic dataset [1]. Insurance can reduce that cost dramatically — but only if your plan covers GLP-1 medications for weight management, and only for branded formulations.

The cash-pay vs insurance cost comparison breaks down into three scenarios. In the first scenario, you have employer-sponsored insurance that covers Wegovy. After meeting your deductible and completing prior authorization, your monthly out-of-pocket for branded Wegovy typically falls between $25 and $150, depending on your plan's specialty drug tier and coinsurance percentage [6]. A BCBS Texas PPO with a $50 specialty copay reduces Wegovy from $1,349/month to $50/month — a 96% reduction. This is the cheapest path if you qualify.

In the second scenario, your insurance does not cover GLP-1 medications for weight loss, or you are on a Marketplace (ACA) plan. Texas Marketplace plans almost universally exclude anti-obesity medications from their formularies [7]. In this case, branded Wegovy costs its full list price of $1,349/month, making compounded semaglutide at $249-350/month the practical choice for most DFW patients. Novo Nordisk's savings card may reduce Wegovy to $0 for commercially insured patients, but uninsured patients and those on government plans do not qualify [3].

In the third scenario, you use a direct primary care (DPC) model. Two DFW clinics — Vitality DPC and Simply Direct Medicine, both in Farmers Branch — operate on membership models that bypass insurance entirely. DPC members pay $299-400/month for semaglutide bundled with primary care access, which can be more cost-effective for patients who also need regular doctor visits and lab work [1].

Prior authorization is required by every major Texas carrier for branded semaglutide. The approval process typically requires documentation of BMI (30+ for obesity indication, or 27+ with a weight-related comorbidity like hypertension, type 2 diabetes, or obstructive sleep apnea), evidence of a failed diet and exercise program, and a prescriber who is willing to complete the paperwork [6]. Approval takes 5-10 business days at BCBS Texas and UnitedHealthcare, and up to 15 business days at Cigna [8]. Denials can be appealed, and approximately 40% of initial GLP-1 denials are overturned on appeal according to 2025 pharmacy benefit data [9].

One important caveat: compounded semaglutide is not covered by any insurance plan. If you choose the compounded route — which 90% of DFW weight-loss clinics prescribe — you are paying cash regardless of your insurance status [4].

Branded vs Compounded Semaglutide: Cost, Quality, and Risk

Branded Wegovy costs $1,349 per month at list price. Compounded semaglutide averages $311 per month across DFW clinics — 77% less [1][3]. That price difference drives most DFW patients toward compounded versions, but the decision involves trade-offs that go beyond cost.

Branded semaglutide (Wegovy, Ozempic) is manufactured by Novo Nordisk under strict FDA oversight. Wegovy is the only semaglutide product FDA-approved specifically for chronic weight management. Each pre-filled pen delivers a precise, verified dose. The medication undergoes batch testing, cold-chain storage requirements, and post-market safety surveillance. If something goes wrong, Novo Nordisk's pharmacovigilance team investigates [3]. The downside is cost: even with the Novo Nordisk savings card (which reduces the price to as low as $0 for eligible commercially insured patients), many patients face $200-500/month out-of-pocket depending on their plan structure [6].

Compounded semaglutide is produced by 503B outsourcing facilities or 503A compounding pharmacies. These pharmacies purchase the raw semaglutide peptide and formulate injectable solutions at doses matching the branded titration schedule. As of March 2026, semaglutide remains on the FDA's drug shortage list, which is the legal basis allowing compounding pharmacies to produce it [4]. When the shortage ends — and the FDA has signaled it may end in 2026 — compounding pharmacies will no longer be permitted to produce semaglutide copies [10].

The quality variance between compounding pharmacies is the primary risk. A 2024 FDA investigation found that 20% of tested compounded semaglutide products contained less active ingredient than labeled, and some contained salt forms (semaglutide sodium) rather than the base form used in Wegovy [11]. Major 503B facilities like Empower Pharmacy (Houston) and Hallandale Compounding submit to regular FDA inspection, but smaller pharmacies may not. DFW patients should ask their clinic which compounding pharmacy supplies their semaglutide and whether that pharmacy holds 503B registration with the FDA.

Here is the honest assessment: compounded semaglutide is significantly cheaper and is the practical choice for the majority of DFW cash-pay patients. It carries more risk than branded Wegovy — no manufacturer backing, variable quality, no FDA approval of the specific finished product, and an uncertain regulatory future. Patients who can afford branded Wegovy or who have insurance that covers it should strongly consider the branded option. Patients who cannot should choose a clinic that sources from a reputable, FDA-registered 503B compounding pharmacy [4][11].

One additional consideration: if the FDA removes semaglutide from the shortage list in 2026, patients currently on compounded semaglutide will need to transition to branded Wegovy or stop treatment. Building a relationship with a clinic that can prescribe branded medications — not just compounded — provides a safety net. Of the 40 clinics in our DFW dataset, we were unable to confirm how many would facilitate that transition [1].

City-by-City Semaglutide Cost Comparison

Semaglutide pricing varies by up to 12% across DFW cities, with Frisco averaging $328/month and Plano averaging $296/month [1]. The table below shows average cash-pay costs by city, based on our verified clinic data as of March 2026. Cities with no verified semaglutide clinics are listed with the nearest city that has providers.

Averages calculated from verified cash-pay monthly pricing as of March 2026. Cities with 0 clinics show nearest alternatives with estimated drive times. Source: SemaVerified clinic database [1].

The pricing pattern across DFW correlates loosely with median household income. Frisco ($141,129 median HHI) and Southlake ($250,001+ median HHI) are the wealthiest cities in our dataset, yet Southlake averages $36/month less than Frisco [12]. This is because Southlake has Medi-Weightloss, a national franchise that uses promotional pricing to acquire patients, pulling the average down. Excluding that promotional outlier, Southlake's average rises to $325/month — comparable to Dallas.

For patients willing to drive 10-15 minutes outside their home city, the savings can be meaningful. A McKinney resident could save $29/month ($348/year) by choosing a Plano clinic averaging $296/month over a Frisco clinic averaging $328/month. An Arlington resident has no local clinics but can access Fort Worth providers at $275-350/month, which is within the DFW average range [1].

Insurance Coverage for Semaglutide by Texas Carrier

Five major carriers dominate the DFW insurance market: BCBS Texas, UnitedHealthcare, Aetna, Cigna, and Molina Healthcare. Coverage for semaglutide varies significantly between carriers, between plan types (employer vs Marketplace vs Medicaid), and even between employer groups within the same carrier [6][7][8].

Blue Cross Blue Shield of Texas covers Wegovy on most employer-sponsored PPO and HMO plans. Prior authorization requires BMI 30+ (or 27+ with comorbidity), documentation of 6+ months of diet/exercise attempts, and a prescribing physician (not NP or PA on some plans). Approval takes 5-10 business days. BCBS Texas places Wegovy on Tier 5 (specialty) with typical copays of $50-150/month after deductible. BCBS Marketplace plans in Texas do not cover Wegovy for weight loss [6]. For Ozempic (diabetes indication), BCBS covers it on Tier 3 with $35-75 copays when prescribed for type 2 diabetes.

UnitedHealthcare (UHC) covers Wegovy on most employer plans and select Medicare Advantage plans as of 2026. UHC's prior authorization is similar to BCBS but also requires a letter of medical necessity from the prescriber. UHC uniquely requires step therapy on some plans — meaning you must try and fail a cheaper weight-loss medication (like phentermine or topiramate) before Wegovy will be approved. Typical copay: $50-200/month. UHC Marketplace plans in Texas exclude Wegovy [6][8].

Aetna covers Wegovy on employer-sponsored plans with prior authorization. Aetna's criteria mirror the FDA label: BMI 30+ or BMI 27+ with comorbidity. Aetna does not require step therapy for Wegovy, making it somewhat easier to get approved than UHC. Copays range from $25-125/month. Aetna Marketplace plans in Texas exclude weight-loss medications [8].

Cigna has the most restrictive GLP-1 coverage among major DFW carriers. Cigna covers Wegovy on select employer plans only, and many large Cigna employer groups have carved out anti-obesity medications entirely due to cost. Prior authorization takes up to 15 business days — the longest among the five carriers. When covered, copays are $75-200/month. Cigna Marketplace and individual plans in Texas do not cover Wegovy [8].

Molina Healthcare is the largest Medicaid managed care provider in Texas. No Texas Medicaid plan covers GLP-1 medications for weight loss as of March 2026. Molina covers Ozempic for type 2 diabetes management only, subject to prior authorization and an endocrinologist or diabetologist referral. This affects approximately 4.2 million Texans on Medicaid [7].

The bottom line for DFW patients: if you have employer-sponsored insurance through BCBS Texas, UHC, or Aetna, there is a reasonable path to getting branded Wegovy covered at $25-200/month. If you are on a Marketplace plan, Medicaid, or a Cigna plan without anti-obesity drug coverage, compounded semaglutide at $249-400/month from a DFW clinic is your primary option. Always call your carrier's pharmacy benefits line (not the main customer service number) and ask specifically: "Is Wegovy covered on my formulary for the obesity indication?" before assuming coverage [6].

How to Save on Semaglutide in DFW

The cheapest path to semaglutide in Dallas-Fort Worth depends on your insurance status, BMI, and willingness to navigate the prior authorization process. Here are five concrete strategies ranked by potential savings, based on our March 2026 pricing data [1].

1. Novo Nordisk Patient Savings Card. If you have commercial insurance (not Medicaid or Medicare), Novo Nordisk's savings program can reduce Wegovy to $0/month for up to 13 fills. The card covers the difference between your copay and $0, with a maximum benefit of $500 per fill. This is the single largest savings opportunity in the DFW market, but it requires a Wegovy prescription (not compounded semaglutide) and commercial insurance with some level of GLP-1 coverage [3]. Approximately 30% of DFW patients who present the card at CVS or Walgreens report the pharmacy cannot process it due to plan restrictions, so confirm with your pharmacy before relying on this [9].

2. First-month promotional programs. Two DFW clinics offer $99 first-month pricing: Medi-Weightloss in Southlake and Rejuvenate IV Bar in Plano [1]. These promotions typically include an initial consultation, baseline lab work, and the first month's medication supply. The catch: ongoing monthly pricing after the promotional period may be higher than the DFW average. Neither clinic publishes its post-promotional pricing, which is a transparency concern. Ask for the total 6-month and 12-month cost before committing.

3. Direct primary care membership. Simply Direct Medicine in Farmers Branch charges $299/month for semaglutide within a DPC model that includes unlimited primary care visits, lab interpretation, and medication management [1]. For patients who currently pay separately for a primary care physician and semaglutide, bundling through a DPC practice can save $100-200/month in aggregate. Vitality DPC, also in Farmers Branch, operates similarly at $300-500/month depending on the medication and dosage.

4. Clinic comparison shopping within your city. Within Dallas alone, prices range from $249/month (InjectCo) to $350/month (four clinics), a spread of $101/month or $1,212/year [1]. In Plano, the range is $99-350/month. A single afternoon of phone calls comparing three clinics can save $600-1,200 annually. Our clinic comparison tool lists all 40 clinics side-by-side.

5. Appeal insurance denials. If your prior authorization for Wegovy is denied, appeal. According to 2025 pharmacy benefit manager data, approximately 40% of GLP-1 prior authorization denials are overturned on first appeal [9]. Your prescribing physician's office should handle the appeal, but you can strengthen it by providing documentation of failed diet programs, comorbidity records, and a personal statement. Some DFW clinics (Elixir 360 Health in Southlake, Lone Star Medical Associates in Plano) explicitly assist with insurance appeals as part of their service [1].

What does not save money: Ordering semaglutide from online-only telehealth platforms headquartered outside Texas. While platforms like Hims, Ro, and Found advertise $199-299/month pricing, these prices often exclude the consultation fee ($49-99), lab work ($75-150), and shipping ($15-25/month). When you add those costs, the all-in price frequently matches or exceeds local DFW clinic pricing, without the benefit of in-person monitoring [2].

Rebates, Federal Incentives & Assistance Programs

Beyond clinic pricing and insurance, several federal programs, manufacturer rebates, and pharmacy incentive structures can reduce your out-of-pocket semaglutide cost by 50-100%. Most DFW patients leave money on the table because these programs aren't advertised at the clinic level. As of March 2026, here is every documented cost-reduction program available to Dallas-Fort Worth patients [3][9].

Manufacturer Patient Assistance Programs (PAPs)

Novo Nordisk Patient Assistance Program. For uninsured or underinsured patients earning below 400% of the federal poverty level ($62,400/year for a single person in 2026), Novo Nordisk provides branded Wegovy at $0/month through their PAP. This is separate from the savings card — it's a full-cost coverage program. Application requires income verification and a prescription from your DFW provider. Processing takes 4-6 weeks, and approval is retroactive to the application date [3]. Approximately 12% of DFW patients who apply are denied due to income documentation issues — submit tax returns, not pay stubs.

Eli Lilly Solutions Center. For tirzepatide (Zepbound/Mounjaro), Lilly's assistance program covers patients with household income under 400% FPL. If your DFW clinic prescribes tirzepatide and you qualify, the medication is provided at $0/month. Eight DFW clinics in our database offer tirzepatide, primarily in Dallas, Frisco, and Southlake [1].

FSA, HSA & HRA Eligibility

Semaglutide prescribed for weight loss by a licensed provider qualifies as an eligible medical expense under Flexible Spending Accounts (FSA), Health Savings Accounts (HSA), and Health Reimbursement Arrangements (HRA). This effectively reduces your cost by your marginal tax rate — 22-24% for most DFW households, or 32-37% for high-income households in Highland Park, Southlake, and University Park [9].

What this means in dollars: A DFW patient paying $311/month (the metro average) in a 24% tax bracket saves $74.64/month by paying through their HSA or FSA — a total of $895/year in tax savings. For branded Wegovy at $500/month after insurance, the HSA/FSA savings reaches $1,440/year. Many DFW employers, particularly in the Las Colinas corridor and Legacy West area, offer high-deductible health plans with HSA contributions that can further offset costs [9].

ACA Preventive Care Coverage

The U.S. Preventive Services Task Force (USPSTF) gives obesity screening and behavioral counseling a "B" recommendation, which under the Affordable Care Act requires insurers to cover these services at $0 copay. While this does not currently mandate $0 semaglutide coverage, it does mean your initial obesity screening, BMI assessment, and counseling visits should be fully covered — saving $150-300 in consultation fees at most DFW clinics [9].

Emerging development: Several advocacy groups are pushing CMS to classify GLP-1 agonists for obesity as preventive care under the ACA framework. If successful, this would require all ACA-compliant plans to cover semaglutide at $0 copay for qualifying patients. As of March 2026, this has not been implemented, but it is worth monitoring — DFW patients on Marketplace plans would benefit the most [9].

Pharmacy Discount & Rebate Programs

Program details verified March 2026. Savings amounts are maximums — actual savings depend on insurance status, pharmacy, and plan details. Cannot stack manufacturer cards with pharmacy discounts.

Employer Wellness Reimbursements

Several large DFW employers — particularly in the Plano/Frisco tech corridor (Toyota, Capital One, JPMorgan Chase) and the Irving/Las Colinas corporate hub (Exxon, Kimberly-Clark, Fluor) — offer wellness reimbursement programs that cover weight management expenses. These programs typically reimburse $500-2,000/year toward physician-supervised weight loss, which can directly offset semaglutide costs [9].

Ask your HR benefits team specifically about: (1) weight management reimbursement, (2) chronic disease management programs that include obesity, and (3) wellness incentive credits that apply to GLP-1 prescriptions. Not all employers advertise these programs proactively — you often have to ask.

What to Avoid

Gray-market semaglutide. Social media sellers offering semaglutide at $50-100/month without a prescription or medical supervision are operating outside FDA and Texas Medical Board regulations. These products are unverified, may be counterfeit or improperly compounded, and carry real health risks. No legitimate savings program operates this way [2].

"Pharmacy kickback" schemes. Some online forums discuss pharmacy rebate stacking or coupon arbitrage. In practice, manufacturer savings cards cannot be combined with GoodRx or similar discount programs — pharmacies will reject the claim. Attempting to stack rebates across multiple programs for the same prescription can also trigger pharmacy benefit manager audits [9].

Semaglutide Cost FAQ